Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1988-6-23
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0133-3909
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
96-101
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3449974-Adult,
pubmed-meshheading:3449974-Drug Therapy, Combination,
pubmed-meshheading:3449974-Female,
pubmed-meshheading:3449974-Humans,
pubmed-meshheading:3449974-Male,
pubmed-meshheading:3449974-Middle Aged,
pubmed-meshheading:3449974-Prazosin,
pubmed-meshheading:3449974-Raynaud Disease,
pubmed-meshheading:3449974-Reserpine,
pubmed-meshheading:3449974-Tolazoline
|
pubmed:year |
1986
|
pubmed:articleTitle |
Minipress treatment of primary Raynaud's disease.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|